Premium
P1‐260: CAN GAIT ANALYSIS AID DIFFERENTIAL DIAGNOSIS OF DEMENTIA DISEASE SUBTYPES?
Author(s) -
Ardle Ríona Mc,
Galna Brook,
Thomas Alan,
Rochester Lynn
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.266
Subject(s) - dementia , gait , physical medicine and rehabilitation , cognition , medicine , cognitive decline , cognitive impairment , disease , audiology , psychology , physical therapy , psychiatry
(A-N+T+, 8%), altered total Tau in 49 (A-N+T-, 11%) and isolated phospho-Tau alterations in 10 cases (A-N-T+, 2%). Conclusions: In the biomarker-based classification of MCI patients, some discrepancies exist regarding staging, nomenclature and interpretation of CSF findings. In this study, we partially replicated previous findings reporting a consistent rate (21%) of MCI patients showing abnormal values of Tau and phospho-Tau without any sign of amyloidosis, defined as Suspected Non-Amyloid Pathology (SNAP). SNAP may represent an entity underlying heterogeneous pathophysiologic processes. Clinical follow-up is mandatory in order to interpret these CSF findings.